Cite
PREVENTION COULD BE LESS COST-EFFECTIVE THAN CURE: THE CASE OF HEPATITIS C SCREENING POLICIES IN FRANCE.
MLA
Sandrine Loubière, et al. “Prevention Could Be Less Cost-Effective Than Cure: The Case of Hepatitis C Screening Policies in France.” International Journal of Technology Assessment in Health Care, vol. 19, no. 4, Dec. 2003, pp. 632–45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=13130828&authtype=sso&custid=ns315887.
APA
Sandrine Loubière, Michel Rotily, & Jean-Paul Moatti. (2003). Prevention Could Be Less Cost-Effective Than Cure: The Case of Hepatitis C Screening Policies in France. International Journal of Technology Assessment in Health Care, 19(4), 632–645.
Chicago
Sandrine Loubière, Michel Rotily, and Jean-Paul Moatti. 2003. “Prevention Could Be Less Cost-Effective Than Cure: The Case of Hepatitis C Screening Policies in France.” International Journal of Technology Assessment in Health Care 19 (4): 632–45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=13130828&authtype=sso&custid=ns315887.